ATE541855T1 - Weitere kristalline formen von rostafuroxin - Google Patents

Weitere kristalline formen von rostafuroxin

Info

Publication number
ATE541855T1
ATE541855T1 AT06819722T AT06819722T ATE541855T1 AT E541855 T1 ATE541855 T1 AT E541855T1 AT 06819722 T AT06819722 T AT 06819722T AT 06819722 T AT06819722 T AT 06819722T AT E541855 T1 ATE541855 T1 AT E541855T1
Authority
AT
Austria
Prior art keywords
crystalline forms
rostafuroxin
forms
βandrostane
triol
Prior art date
Application number
AT06819722T
Other languages
English (en)
Inventor
Alberto Cerri
Silvia Armaroli
Marco Torri
Original Assignee
Rostaquo S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rostaquo S P A filed Critical Rostaquo S P A
Application granted granted Critical
Publication of ATE541855T1 publication Critical patent/ATE541855T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT06819722T 2005-11-25 2006-11-23 Weitere kristalline formen von rostafuroxin ATE541855T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025817 2005-11-25
PCT/EP2006/068845 WO2007060206A2 (en) 2005-11-25 2006-11-23 Further crystalline forms of rostafuroxin

Publications (1)

Publication Number Publication Date
ATE541855T1 true ATE541855T1 (de) 2012-02-15

Family

ID=36165370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06819722T ATE541855T1 (de) 2005-11-25 2006-11-23 Weitere kristalline formen von rostafuroxin

Country Status (10)

Country Link
US (1) US9127037B2 (de)
EP (1) EP1951738B1 (de)
AT (1) ATE541855T1 (de)
CY (1) CY1112973T1 (de)
DK (1) DK1951738T3 (de)
ES (1) ES2380491T3 (de)
PL (1) PL1951738T3 (de)
PT (1) PT1951738E (de)
SI (1) SI1951738T1 (de)
WO (1) WO2007060206A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
EP2490694B1 (de) * 2009-10-19 2015-09-16 Rostaquo S.p.A. Rostafuroxin zur pharmakogenomischen behandlung von herz-krleislauf-erkrankungen
WO2012066141A1 (en) 2010-11-19 2012-05-24 Fondazione Centro San Raffaele Del Monte Tabor Markers for acute kidney injury and uses thereof
CN102940640A (zh) * 2012-12-06 2013-02-27 中国生命药物治疗有限公司 罗他夫辛在制备治疗基因缺陷型原发性高血压的药物中的用途
CN108096207B (zh) * 2017-12-29 2021-01-01 兆科药业（合肥）有限公司 一种罗他夫辛肠溶片的制备方法
US11337988B2 (en) 2018-09-27 2022-05-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of ouabain antagonists to inhibit viral infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
IT1282286B1 (it) * 1995-05-11 1998-03-16 Sigma Tau Ind Farmaceuti Seco-d steroidi sul sistema cardiovascolare, processi per la loro preparazione e composizioni farmaceutiche che li contengono.

Also Published As

Publication number Publication date
DK1951738T3 (da) 2012-04-23
PL1951738T3 (pl) 2012-06-29
CY1112973T1 (el) 2016-04-13
ES2380491T3 (es) 2012-05-14
WO2007060206A3 (en) 2007-08-30
SI1951738T1 (sl) 2012-06-29
WO2007060206A2 (en) 2007-05-31
PT1951738E (pt) 2012-04-18
EP1951738B1 (de) 2012-01-18
EP1951738A2 (de) 2008-08-06
US20080300228A1 (en) 2008-12-04
US9127037B2 (en) 2015-09-08

Similar Documents

Publication Publication Date Title
HUE042561T2 (hu) Anti-IL-23-ellenanyagok, készítmények, eljárások és alkalmazások
TW200732349A (en) Anti-OX40L antibodies and methods using same
IL192631A (en) A drug containing an isolated antibody or a functional portion thereof, pharmaceutical preparations and a kit containing it
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
ATE553792T1 (de) Medizinische vorrichtungen mit verbundstoffen
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
WO2011047087A3 (en) Protein detection via nanoreporters
BRPI0607279A2 (pt) composição compatìvel com fertilizante
EP2207568A4 (de) Für die protofibrillenform des proteins beta-amyloid spezifische antikörper
JO2515B1 (en) Gamma-Crystalline form of ivabradine hydrochloride,a process for its preparation and pharmaceutical composition containing it
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
MX2010006576A (es) Composiciones y metodos para producir isopreno.
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
BRPI0716495A2 (pt) (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos.
IL194550A (en) Isolated antibodies or their fragments that bind to human protein tyrosine phosphate in a cell, their pharmaceutical preparations and their use
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
GT200600264A (es) Modificaciones cristalinas de piraclostrobina
CL2008002092A1 (es) Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
EP2128253A4 (de) Antikörper gegen fgf23 und pharmazeutische zusammensetzung damit
CY1112973T1 (el) Περαιτερω κρυσταλλικες μορφες ροσταφουροξινης
EA200600404A1 (ru) Пероральные препаративные формы кладрибина